Olumiant (Baricitinib)

Olumiant Information:

Buy Olumiant

Olumiant (Baricitinib) is used alone or in combination with other medications, such as methotrexate, to treat moderate to severe active rheumatoid arthritis in patients who have not responded to other first-line treatments. It is also used to treat inflammatory skin and scalp conditions, such as severe alopecia areata and atopic dermatitis. Additionally, it is used in the treatment of suspected or confirmed COVID-19 infection in critical patients requiring oxygen support. Its active ingredient, baricitinib, belongs to the class of drugs known as Janus kinase (JAK) inhibitors. Baricitinib works by targeting and inhibiting specific enzymes involved in the inflammatory process that occurs in these medical conditions, thereby alleviating associated inflammatory signs and symptoms.

Generic Olumiant from Canada

Canada Drugs Online is proud to serve you the brand Olumiant from Canada manufactured by Eli Lilly. The generic form of this medication is currently not available. Please call us toll-free at 1-877-900-3784 for details.

CanadaDrugsOnline.com also carries other Arthritis & Anti-Inflammatory Medications such as Arcoxia and Otezla.

Olumiant Side Effects:

Common mild side effects of this medication include acne, cold sores, runny nose, sinus congestion, constipation, cough, diarrhea, dizziness, fatigue, headaches, heartburn, joint pain, mouth and throat pain, muscle spasms, nausea, mild rash, sinus infection, stomach pain, trouble sleeping, and vomiting. Contact your doctor if these mild side effects persist or worsen.

Possible serious side effects of this medication include unusual tiredness, pale skin, fast heartbeat, persistent nausea and vomiting, loss of appetite, severe abdominal pain, yellowness of the eyes and skin, passage of dark urine, fever, severe dizziness, fainting, increased blood pressure, pain when urinating, urinating more often than usual, low back or flank pain, vaginal itching, burning, soreness, whitish-grey cottage cheese-like vaginal discharge, tenderness, pain, swelling, warmth, or redness in the arm or leg, sharp chest pain that is worst when breathing in, coughing up blood, sweating, sudden or severe headache, sudden loss of coordination, vision changes, sudden slurring of speech, unexplained weakness, numbness, or pain in arm or leg, severe body itching, rash, swelling of your face, lips, tongue, or throat, difficulty breathing, and dizziness. Discontinue this medication and seek immediate medical attention if you observe these severe side effects. Additionally, inform your doctor about any other side effects not listed here.

Olumiant (Baricitinib) has been established in different clinical trials to be effective in treating rheumatoid arthritis, alopecia areata, and COVID-19 with minimal but rare adverse effects such as an increased risk of tuberculosis infections, cancer, and thrombosis. It has a consistently good safety profile in most individuals, even when used over a long time, as studies suggest. The half-life of Baricitinib is approximately 12 hours.

Olumiant Directions:

Olumiant is available in tablets and is typically taken orally, with or without food. The specific dosage and frequency depend on the condition being treated. Your doctor will determine the appropriate dose for you. Refer to the leaflet in the medication pack for more usage details. Use this medication regularly as prescribed, and do not adjust the dose without consulting your doctor. Store this medication at room temperature, protect it from light and moisture, and keep it out of the reach of children.

Olumiant Precautions:

Before using Olumiant, ensure you inform your doctor about any past or current personal or family history of medical conditions, especially the following:
• Allergic reaction to Baricitinib, other ingredients of Olumiant, or any other medication;
• Abdominal problems such as peptic ulcer, diverticulitis;
• Active infections in the body such as tuberculosis, hepatitis;
• Blood or bone marrow problems such as anemia;
• Blood clot disorders such as pulmonary embolism, deep venous thrombosis;
• Cancer;
• Heart disease such as a heart attack;
• High blood cholesterol;
• Inflamed lungs;
• Kidney disease;
• Liver disease;
• Stroke

Inform your healthcare provider that you are taking this medication before getting a vaccine. Avoid contact with individuals with infections such as tuberculosis, measles, and chicken pox while taking this medication, as you may be at high risk of getting these infections. Check with your doctor regularly while taking this medication, as regular blood tests may need to be done to monitor its effects in your body. This medication should not be used during pregnancy or while breastfeeding. It should be used with caution in elderly individuals, as they are at higher risk of developing side effects. This medication is not recommended for use in children younger than 2 years. Some medications may interact with Baricitinib, affecting the way it works in the body. Such medications include:
• Abatacept;
• Adalimumab;
• Cyclosporine;
• Etanercept;
• Ethacrynic acid;
• Upadacitinib

Therefore, make sure you inform your doctor about all the medications, including herbal medications and supplements you are taking before starting Olumiant to prevent drug interactions.